[
フレーム]
Please make JavaScript on and see this site.
Back
-
Regulations & Services of PMDA
Information about Approved Products in Japan
-
Information for approved products in Japan
-
Development of Drugs, Medical devices, Regenerative medicines and in Vitro diagnostics
Information for approved products in Japan
-
Regulations and services of PMDA
Information for approved products in Japan
Back
-
Regulations and Services of PMDA
Information for apporoved products in Japan
-
Regulations and Services of PMDA
Information for apporoved products in Japan
-
Reviews and Related Services
Post-marketing Safety Measures
-
Reviews and Related Services
Post-marketing Safety Measures
Regulatory Science/The Science Board/Standard Development
The 1st Subcommittee on Rare Cancers
Press Release
Date and Time: October 19, 2016 from 5pm to 7pm
Agenda / List of Handouts
Agenda
- Introduction of the Subcommittee members
- About the Science Board and the Subcommittees
- Drug Evaluation for Rare Diseases (Dr. Mamoru Narukawa, a Member of the Subcommittee) (Result Summary of Health and Labor Sciences Research)
- Drug Development for Rare Cancers (from Point of View of a Clinician) (Dr. Masashi Ando, a Member of the Subcommittee)
- Points to Consider and Future Plan
- Others
List of Handouts
- Document 1 Scope of the Subcommittee
- Document 2 Report of Health and Labor Sciences Research
- Document 3 Summary of Opinions from the Committee
- Document 4 Lecture Materials (Dr. Mamoru Narukawa, a Member)
- Document 5 Lecture Materials (Dr. Masashi Ando, a Member)